Haematologica Reports

Introduction
Douglas E. Joshua

Thalidomide alone or in combination: results in refractory patients
Jesús F. San Miguel

Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan versus melphalan, prednisone, and thalidomide
Mario Boccadoro

The Intergroupe Francophone du Myélome experience with thalidomide
Jean-Luc Harousseau, Michel Attal, Thierry Facon, Ibrahim Yakoub-Agha

Thalidomide plus dexamethasone as initial therapy for multiple myeloma: overview of Mayo Clinic and Eastern Cooperative Oncology Group experience
Robert A. Kyle, S. Vincent Rajkumar

Panel Discussion